Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,835.89
    -41.16 (-0.52%)
     

  • Bitcoin USD

    64,784.55
    +3,122.78 (+5.06%)
     

  • CMC Crypto 200

    1,337.86
    +25.24 (+1.96%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • Dow

    37,775.38
    +22.07 (+0.06%)
     

  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     

  • Gold

    2,396.40
    -1.60 (-0.07%)
     

  • Crude Oil

    82.48
    -0.25 (-0.30%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Motus GI to Release Third Quarter Results and Provide a Business Update on November 12

Motus GI Holdings, Inc.
·1-min read

FORT LAUDERDALE, Fla., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its third quarter financial results on Friday, November 12, 2021, before the market open. Management will host a conference call and webcast at 8:30 a.m. ET to discuss the results and provide updates on recent corporate developments.

Conference Call and Webcast

Date and Time:

Friday, November 12th at 8:30 a.m. ET

Domestic:

877-407-0792

International:

201-689-8263

Passcode:

13723885

Webcast:

www.motusgi.com or http://public.viavid.com/index.php?id=146872

A replay of the webcast will be archived on the Motus GI website, www.motusgi.com, for 90 days following the event.

About Motus GI

Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.

For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.

Investor Contact:
Bob Yedid
LifeSci Advisors
(646) 597-6989
bob@lifesciadvisors.com